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What turned you on to biology in 
the first place? Bodies of water 
are often involved here, aren’t they? 
For me it was a local swamp, where 
I caught frogs, snakes, waterbugs, 
things that Mom was not happy to 
see arrive home with me. Biology 
really got interesting, though, when 
I received a small microscope one 
Christmas, and started looking at 
drops of swamp water. The variety of 
different protozoa, rotifers, and so on 
swimming in that water was quite a 
shock. I drew the different species of 
protozoa on index cards and looked 
them up in a book at the public library. 
I still have that little microscope on 
a shelf in my office! Also, like a lot 
of American biologists, I was greatly 
influenced by a superb high school 
biology teacher. You have to tip your 
hat to those folks — they have quite 
an impact. 
What is your favourite conference? 
The most recent one I’ve been invited 
to! Seriously, I love the Gordon 
Conferences for all of the usual 
reasons — small size, latest science, 
lots of opportunity to talk informally. 
But the ASCB meeting will always be 
tops for me. It was the first meeting 
I ever attended as a grad student 
(Anaheim, 1981) and it convinced me 
that it was going to be really exciting 
to do science. All of those bright 
Q & A people doing all of that cool stuff! It is the one meeting that I push members 
of my lab to attend. It’s way too big 
to get your brain around, and it’s 
a mentally exhausting week. But it 
brings together such a wide range of 
great work and great people that it is 
hard to beat.
What is your greatest ambition in 
research? To carry the questions I 
am interested in — of the transport 
and activity of mitochondria in the 
nervous system — into animal models 
of human disease. For decades cell 
biologists have been telling granting 
agencies that they should fund our 
studies because eventually they 
would be directly relevant to human 
health and disease. Well, guess what? 
In the past decade this has turned 
out to be absolutely right! So now I 
think the pressure’s on us to try to 
use the wealth of animal models to 
study our basic biological questions. 
We want to design experiments that 
tell us both about a basic question 
like how mitochondria are distributed 
in neurons, and also about how 
defects in this process underlie 
neurodegenerative disease. It’s  
pay-back time.
What has been your biggest 
mistake in your research career? 
I wish that I had moved into a 
genetically tractable system much 
earlier. Maybe with all of the genomes 
being sequenced and annotated, and 
new means available to manipulate 
gene expression in a lot of systems, 
this will become less important. But 
I doubt it. I would still advise any 
young biologist: get training in a 
manageable, robust genetic  
system — yeast, fly, worm, 
Arabidopsis, zebrafish. It puts you 
atop a very tall pyramid of previous 
work, and gives you unique tools for 
answering so many questions.
Do you have a scientific hero? Well, 
this will sound odd for a biologist, but 
my hero worked on electromagnetism 
and electrochemistry. That would 
be Michael Faraday, probably the 
greatest experimentalist in the history 
of science. His story is so compelling: 
he came up from the working class, 
was a bookbinder’s apprentice, self-
educated, real Dickensian stuff. He 
started as a lab grunt with Humphry 
Davy, but in the end he had the most 
extraordinary career at the bench that you can imagine. So much 
fundamental work, and he did the 
dirty work himself — he even blew 
himself up several times. And he gave 
masterful lectures about his work 
to scientists and the general public. 
We talk a lot now about translational 
research, but look at what Faraday’s 
basic research ‘translated’ into — most 
of the underpinnings of how we use 
energy in the modern world. I drag my 
cell biology students through some 
thermodynamics and when we come 
to the Faraday constant, I always 
take time to tell them his story. A 
living influence, too: my postdoctoral 
mentor, Dennis Bray. He is a truly 
original thinker who has reinvented 
himself scientifically twice in his career 
and proceeded to make landmark 
contributions each time. 
Do you think we’re on the cusp of 
a change in biological research 
and the career structure of 
biologists? Well, research in life 
sciences seems to be headed toward 
a place where some big discoveries 
will require a different sort of training 
background, and maybe a different 
kind of operator, than is typical 
now. Think of the increasing impact 
of relatively new ways of thinking: 
theoretical approaches to complexity, 
computational approaches to large 
datasets. But when I hear predictions 
that we’ll all be doing ‘big science’ in 
the future, I feel the same skepticism 
that I did 20 years ago when a crew of 
24-year-olds were telling us that soon 
we would all be making our living on 
the internet. Look, if you’ve spent 
any time in administration, you know 
that some of the enthusiasm for big 
biology involves the need for research 
institutions to win the very large grant 
awards that can be garnered by huge 
collaborative groups — much larger 
than the RO1s brought in by the 
likes of me. I’ve no doubt that some 
great things will be achieved by large 
interdisciplinary groups, assembled 
from above, along the lines of high-
energy physics during the last century. 
But I suspect that a lot of great new 
ideas in biology will still originate in 
one brain, or a few sympatico brains, 
and that fundamental advances will 
still be made by small numbers of 
hands. I would bet on the departments 
or centers that can assemble a critical 
mass of investigators each with 
their own research questions and 
approaches, but with a rich matrix 
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in a good physical plant with lots of 
shared space, and let them go to it. 
When it comes to the size of individual 
research groups, there’s a value-for-
money issue too — we are mostly 
spending the taxpayers’ coin, after all. 
I have always had the impression that 
individual laboratory groups larger 
than about a dozen full-time workers 
produce less science per dollar spent 
than smaller groups. 
We hear American academics 
talk about the balance between 
research and teaching. You’re at 
a public university with tens of 
thousands of students — how do 
you view it? It is a tricky balance. 
Universities tend to reward research 
progress rather well and teaching 
success less so, at least in tangible 
career progress. But when you think 
about it, the range of activities that we 
carry out — doing research, training 
postgrads and postdocs, and teaching 
and advising undergraduates — is 
really a continuum. Research attracted 
most of us to this life, but in the public 
universities we also have an enormous, 
mandated public mission: to educate 
the students of our state, the nation 
and the world in science. And a great 
thing about being a science student 
in our research universities is that 
you are being taught mainly by active 
researchers: your neuroscience course 
is taught by a working neuroscientist, 
cell biology by a cell biologist, and 
so on. For part of the academic year 
I’m that guy, trying to make it seem 
worthwhile to hundreds of 19-year-
olds to spend 15 weeks studying cell 
biology, trying to convey to them the 
excitement of this field. You can hardly 
fault academics who dodge a  
teaching assignment like that. 
Not everyone has the inclination 
or aptitude for teaching, and the 
incentive system can push you away 
from it. Still, if you take a pass on it, 
I think you’re missing the boat. It’s 
hard for a young assistant professor 
to believe, but your effect on students 
in the classroom will probably bring 
you closer to immortality than even 
your best paper. Our papers grow 
old and disappear, but, as Garrison 
Keillor says, “nothing you do for young 
people is ever wasted.” 
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When I recently unwrapped my weekly 
delivery of German magazine Der 
Spiegel, my fiancée thought she’d 
caught me ordering from the top 
shelf (she always had doubts about 
that particular magazine, despite my 
assurances that it is in fact one of 
Europe’s largest news magazines). 
On the cover was a blond woman 
(it is German after all) rising from a 
computer-generated ocean. Around 
her naked breasts (it is European after 
all) the water was spiralling in the 
shape of a double helix. The headline 
read: “The victory over the genes. 
Smarter, healthier, happier. How we 
can outwit our genome.” Inside was a 
ten-page spread about epigenetics.
Epigenetics is of course being 
considered ‘sexy’ in vast circles of the 
scientific world (and has attracted the 
funding to go with it), but that Spiegel 
cover was a different type of ‘sexy’. 
This kind of public attention seemed 
unusual: molecular biology rarely 
makes it to the front page. And what’s 
more, this wasn’t just some German 
oddity: Newsweek had last year a 
similar cover story, touting a revolution 
in biology in gonzo-journalism style: 
“Roll over, Mendel. Watson and Crick? 
They are so your old man’s version of 
DNA”. Likewise, the New York Times 
is in tune, as a news piece last year 
celebrated the role of the ‘epigenome’ 
in controlling “which genes are on or 
off”; nor is the hype confined to the 
popular press, as a recent editorial 
in Nature also noted that: “genome 
sequences, within and across species, 
were too similar to be able to explain 
the diversity of life. It was instead clear 
that epigenetics — those changes to 
gene expression caused by chemical 
modification of DNA and its associated 
proteins — could explain much about 
how these similar genetic codes are 
expressed uniquely in different cells, in 
different environmental conditions and 
at different times”.
The term ‘epigenetics’ itself is 
fraught with misunderstandings (for 
an in-depth discussion, see an essay 
by Mark Ptashne, Curr. Biol. 17, 
R233–R236). Initially coined by the 
My Wordgeneticist C.H. Waddington as “the 
branch of biology which studies the 
causal interactions between genes 
and their products which bring the 
phenotype into being”, the word 
epigenetics has undergone one of 
these curious shifts of meaning that 
characterise language evolution and 
are often the source of fundamental 
misunderstandings. Nowadays, as 
evident in the above quoted Nature 
editorial, ‘epigenetics’ is often used to 
flatly refer to chemical modifications 
of the DNA itself (methylation) or 
its associated protein scaffold, the 
histones. 
This was exactly the way epigenetics 
was used in the Spiegel piece: a 
graphic about ‘switches in the genome’ 
showed DNA methylation and histone 
modifications. A tiny blob in the bottom 
right corner symbolised a ‘gene 
activating protein’, otherwise there was 
no mention of signalling pathways or 
transcription factors in the entire  
article — the things that for half a 
century now have been known to be 
what brings ‘the phenotype into being’. 
The article itself was mainly concerned 
with listing examples supporting the 
notion that ‘genes aren’t everything’: 
on the one hand, cases where genetic 
predisposition, e.g. for adiposity, 
does not lead to the development of 
that phenotype, as well as the much-
discussed weaknesses in genome-
wide association studies to pick up 
causative genetic agents for common 
diseases; on the other hand, examples 
of how the environment can influence 
‘Victory over the genes’: Cover of Der Spiegel 
on epigenetics. © 2010 DER SPIEGEL.
